Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

OptimizeRx Corp (OPRX) USD0.001

Sell:$50.00 Buy:$53.10 Change: $0.42 (0.81%)
Market closed |  Prices as at close on 16 April 2021 | Switch to live prices |
Change: $0.42 (0.81%)
Market closed |  Prices as at close on 16 April 2021 | Switch to live prices |
Change: $0.42 (0.81%)
Market closed |  Prices as at close on 16 April 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

OptimizeRx Corporation is a digital health company that facilitates communication at point-of-care among stakeholders in healthcare. The Company provides electronic clinical information through electronic health records (EHRs) to the medical profession, providing a direct channel for pharmaceutical companies to communicate with healthcare providers. Primarily focused on life science and payer clients, its suite of digital and mobile software as a service (SaaS)-based solutions enables affordability, patient adherence and care management. The Company’s products and applications include financial messaging, brand and clinical messaging, brand support, patient engagement and digital therapeutics. Its integrated financial messaging platform is a virtual patient support center that allows doctors and staff to access a universe of sample vouchers, co-pay coupons and other patient support through their electronic medical record (EMR) and/or e-Prescribe systems.

Contact details

400 Water St Ste 200
United States
+1 (248) 6516558

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$843.69 million
Shares in issue:
16.81 million
Health Care Technology
United States
US dollar

Key personnel

  • Gus Halas
    Chairman of the Board
  • Miriam Paramore
  • William Febbo
    Chief Executive Officer, Director
  • Douglas Baker
    Chief Financial Officer
  • Angelo Campano
    Senior Vice President - Principal of Agency Channels
  • Todd Inman
    Chief Technology Officer
  • Marion Odence-Ford
    Chief Compliance Officer, General Counsel
  • Stephen Silvestro
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.